These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6323979)

  • 1. [Effect and tolerance of the angiotensin-converting enzyme inhibitor captopril (Tensobon)].
    Rahn KH; Stumpe KO
    MMW Munch Med Wochenschr; 1984 Feb; 126 Suppl 1():S5-14. PubMed ID: 6323979
    [No Abstract]   [Full Text] [Related]  

  • 2. Captopril and enalapril: angiotensin converting enzyme (ACE) inhibitors.
    Ferguson RK; Vlasses PH; Riley LJ
    Ration Drug Ther; 1984 Mar; 18(3):1-5. PubMed ID: 6093192
    [No Abstract]   [Full Text] [Related]  

  • 3. [Captopril (Tensobon) in practical use in hypertension and heart failure].
    Philipp T; Lederle RM
    MMW Munch Med Wochenschr; 1984 Feb; 126 Suppl 1():S15-23. PubMed ID: 6424002
    [No Abstract]   [Full Text] [Related]  

  • 4. Beneficial haemodynamic effect of the angiotensin blocking agent captopril in patients with refractory heart failure.
    Lee CL; MacDonald GJ; Walsh WF
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():93-7. PubMed ID: 6291831
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II].
    Schalekamp MA; de Bruyn JH; Wenting GJ; Man in 't Veld AJ; Derkx FH
    Ned Tijdschr Geneeskd; 1980 Nov; 124(47):1996-2003. PubMed ID: 6255350
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors.
    Dipalma JR
    Am Fam Physician; 1980 Nov; 22(5):164-5. PubMed ID: 6158857
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure (author's transl)].
    Kayanakis JG; Giraud P; Puel J; Cassagneau B; Sabot G; Fauvel JM; Bounhoure JP
    Nouv Presse Med; 1981 Apr; 10(19):1583-6. PubMed ID: 6269558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of angiotensin-converting enzyme: therapeutic implications.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Isr J Med Sci; 1982 Oct; 18(10):981-5. PubMed ID: 6293997
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current aspects of the clinical effectiveness and tolerance of captopril in the treatment of cardiovascular diseases].
    Ol'binskaia LI; Mokhova OV
    Ter Arkh; 1984; 56(11):139-42. PubMed ID: 6395426
    [No Abstract]   [Full Text] [Related]  

  • 10. [Captopril inhibits angiotensin converting enzyme. New principles for therapy in hypertension and heart failure].
    Ohman KP; Karlberg BE
    Lakartidningen; 1981 Nov; 78(45):4039-41. PubMed ID: 6276631
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of chronic congestive cardiac insufficiency with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
    Guerrera G; Melina D
    Minerva Cardioangiol; 1983 Mar; 31(3):93-100. PubMed ID: 6304571
    [No Abstract]   [Full Text] [Related]  

  • 12. [Angiotensin-converting enzyme inhibition: a pathophysiologically based concept for the therapy of hypertension and heart failure].
    Stumpe KO; Overlack A; Kolloch R
    Dtsch Med Wochenschr; 1984 Aug; 109(34):1295-9. PubMed ID: 6088205
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of essential arterial hypertension of moderate severity with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
    Guerrera G; Melina D
    Minerva Cardioangiol; 1983 Mar; 31(3):101-6. PubMed ID: 6304570
    [No Abstract]   [Full Text] [Related]  

  • 14. Captopril: an oral angiotension converting enzyme inhibitor active in man.
    Brunner HR; Gavras H; Waeber B; Turini GA; Wauters JP
    Arch Int Pharmacodyn Ther; 1980; Suppl():188-212. PubMed ID: 6251762
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of chronic refractory cardiac insufficiency with an inhibitor of converting enzyme. Long-term results].
    Charbonnier B; Monpère C; Desveaux B; Cosnay P; Fauchier JP; Brochier M
    Ann Cardiol Angeiol (Paris); 1984; 33(4):233-7. PubMed ID: 6087714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of prostaglandins and kinin-kallikrein system in heart failure].
    Yui Y; Kawai C
    Nihon Rinsho; 1983 Dec; 41(12):2735-9. PubMed ID: 6325759
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute inhibition of angiotensin-converting enzyme by captopril. Hemodynamic and biochemical aspects in normotension and essential hypertension].
    Stanek B; Templ H; Pohanka E; Silberbauer K
    Acta Med Austriaca; 1982; 9(5-6):175-80. PubMed ID: 6299046
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of captopril in the management of cardiac failure.
    Cleland JG; Dargie HJ; Robertson JI; Ball SG; Hodsman GP
    Scott Med J; 1984 Apr; 29(2):129-30. PubMed ID: 6099613
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute effects of angiotensin I converting enzyme inhibitor, captopril (SQ 14, 225) on severe heart failure--hemodynamics, plasma catecholamine levels, renin-angiotensin-aldosterone system and blood gas data (author's transl)].
    Morimoto Y; Baba M; Takahashi T; Fujii M; Konishi T; Kawanami C; Hamada M; Nakano T; Takezawa H
    Kokyu To Junkan; 1982 Mar; 30(3):317-25. PubMed ID: 6808624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.